Pharma Companies

164 companies | Large pharmaceutical companies

#	COMPANY	THERAPEUTIC AREAS	STAGE
1.	Adamed Pharma Pieńków, Poland	Cardiovascular Neuroscience Oncology	Commercial	VIEW
2.	Ajanta Pharma Mumbai, India	Ophthalmology Cardiovascular Dermatology+1	Commercial	VIEW
3.	Alexion Pharmaceuticals Boston, USA	Hematology Neuroscience Metabolic+2	Commercial	VIEW
4.	Alkaloid AD Skopje Skopje, North Macedonia	Gastroenterology Cardiovascular Neuroscience+1	Commercial	VIEW
5.	Alkem Laboratories Mumbai, India	Infectious Disease Gastroenterology Cardiovascular+4	Commercial	VIEW
6.	Almirall Barcelona, Spain (Ronda General Mitre, 151, Barcelona, 08022)	Dermatology	Phase 1, Phase 2, Phase 3, Commercial	VIEW
7.	Amgen Thousand Oaks, California, United States	Oncology Immunology Metabolic+1	Discovery through Commercial	VIEW
8.	Asian Institute of Technology Pathum Thani, Thailand		Discovery	VIEW
9.	Aspen Pharmacare Holdings Limited uMhlanga, South Africa	Oncology Vaccines	Commercial (Focus on post-patent branded generics rather than R&D pipeline)	VIEW
10.	Astellas Pharma Inc. Tokyo, Japan	Oncology Ophthalmology Immunology+2	Discovery to Phase 3	VIEW
11.	AstraZeneca Cambridge, United Kingdom	Oncology Cardiovascular Rare Diseases+1	Phase 1\|Phase 2\|Phase 3\|Pre-registration\|Commercial	VIEW
12.	BASF Ludwigshafen, Germany	Immunology	Commercial	VIEW
13.	Bangkok Dusit Medical Services (BDMS) Bangkok, Thailand	Oncology Cardiovascular Neuroscience+1	Commercial	VIEW
14.	Bausch Health Laval, Canada	Gastroenterology Dermatology Neuroscience+1	Commercial	VIEW
15.	Bayer Leverkusen, Germany	Oncology Cardiovascular Neuroscience+3	Discovery through Commercial	VIEW
16.	Berlin Pharmaceutical Industry Co., Ltd. Bangkok, Thailand	Cardiovascular Gastroenterology Respiratory	Commercial	VIEW
17.	Berlin-Chemie AG Berlin, Germany	Cardiovascular Metabolic Respiratory+2	Commercial	VIEW
18.	Biocon Limited Bengaluru, India	Oncology Immunology Ophthalmology+2	Commercial, Phase 3, Phase 2, Phase 1	VIEW
19.	Biogen Cambridge, Massachusetts, USA		Phase 1-Phase 3; Commercial	VIEW
20.	Bionorica SE Neumarkt in der Oberpfalz, Germany	Respiratory Immunology	Commercial	VIEW
21.	Biotest AG Dreieich, Germany		Phase 3	VIEW
22.	Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt)	Metabolic Immunology Oncology+2	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
23.	Boryung Seoul, South Korea	Oncology Cardiovascular Neuroscience+1	Commercial	VIEW
24.	Bracco Imaging S.p.A. Milan, Italy	Oncology Cardiovascular Neuroscience+1	Commercial	VIEW
25.	Bristol Myers Squibb Princeton, New Jersey, United States	Oncology Immunology Neuroscience+2	Phase 1-3 and Commercial	VIEW
26.	CIBC Toronto, Canada		Commercial	VIEW
27.	CSL Limited Melbourne, Australia	Immunology Hematology Cardiovascular+3	Commercial	VIEW
28.	CSL Limited (CSL Behring is the largest division) Melbourne, Australia (corporate); King of Prussia, USA (CSL Behring)	Immunology Hematology Respiratory+1	Phase 1 through Commercial	VIEW
29.	CSL Seqirus Maidenhead, United Kingdom		Commercial	VIEW
30.	Celltrion Incheon, South Korea	Immunology Oncology Ophthalmology+2	Commercial	VIEW
31.	Cencora Conshohocken, Pennsylvania, United States	Oncology Cell Therapy Gene Therapy+1	Commercial (as distributor/logistics provider)	VIEW
32.	Cencora Conshohocken, Pennsylvania, USA	Oncology Rare Diseases	Commercial	VIEW
33.	Chiesi Farmaceutici Parma, Italy		Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
34.	China Resources Double-Crane Pharmaceutical Co., Ltd. Beijing, China	Cardiovascular Metabolic Oncology+2	Commercial	VIEW
35.	China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Shenzhen, China	Respiratory Gastroenterology Cardiovascular+2	Commercial	VIEW
36.	Chong Kun Dang Pharmaceutical Corp. Seoul, South Korea	Oncology Cardiovascular Metabolic+3	Commercial	VIEW
37.	Chugai Pharma Taiwan Ltd. Taipei, Taiwan	Oncology Hematology Immunology+2	Commercial	VIEW
38.	Chugai Pharmaceutical Co., Ltd. Tokyo, Japan	Oncology Immunology Hematology+2	Commercial	VIEW
39.	Citadel Miami, USA		Commercial	VIEW
40.	Coca-Cola Europacific Partners Uxbridge, United Kingdom		-	VIEW
41.	Cofares Madrid, Spain		Commercial	VIEW
42.	DLL (De Lage Landen Financial Services) Eindhoven, Netherlands (Global); Wayne, PA (US)		Commercial	VIEW
43.	Daewon Pharmaceutical Co., Ltd. Seoul, South Korea	Respiratory Neuroscience Cardiovascular+1	Commercial	VIEW
44.	Daewoong Pharmaceutical Seoul, South Korea	Gastroenterology Metabolic Immunology+1	Commercial	VIEW
45.	Daiichi Sankyo Chuo, Tokyo, Japan	Oncology Immunology	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
46.	Danone Paris, France		Commercial	VIEW
47.	Dawnrays Pharmaceutical Suzhou, China	Cardiovascular	Commercial	VIEW
48.	Dechra Pharmaceuticals Northwich, United Kingdom	Metabolic Dermatology Cardiovascular	Commercial	VIEW
49.	Dr. Reddy's Laboratories Ltd. Hyderabad, India	Oncology Immunology Gastroenterology+3	Commercial	VIEW
50.	Ecolab Inc. Saint Paul, USA	Oncology Immunology Rare Diseases	Commercial	VIEW
51.	Eczacıbaşı Pharmaceutical and Industrial Investment Co. Istanbul, Turkey	Oncology Hematology Infectious Disease+3	Commercial	VIEW
52.	Eisai Pharmaceuticals India Mumbai, India	Neuroscience Oncology Gastroenterology	Commercial	VIEW
53.	Eli Lilly and Company Indianapolis, Indiana, USA	Oncology Immunology Neuroscience+1	Phase 1-Phase 3 and Commercial	VIEW
54.	Esteve Healthcare Barcelona, Spain	Neuroscience Oncology Rare Diseases+3	Commercial	VIEW
55.	Export-Import Bank of Korea Seoul, South Korea	Oncology Immunology Gene Therapy	Commercial	VIEW
56.	Farmindustria Rome, Italy	Oncology Immunology Neuroscience+3	Commercial	VIEW
57.	Ferozsons Laboratories Limited Lahore, Pakistan	Gastroenterology Cardiovascular Oncology+3	Commercial	VIEW
58.	Ferrer Barcelona, Spain	Neuroscience Cardiovascular Dermatology+1	Commercial	VIEW
59.	Ferring Pharmaceuticals Saint-Prex, Switzerland	Gastroenterology Metabolic	Commercial	VIEW
60.	Fidelity Investments Boston, USA	Oncology Neuroscience Rare Diseases+3	Commercial	VIEW
61.	Fosun Pharma Shanghai, China	Oncology Neuroscience Cardiovascular	Commercial	VIEW
62.	Fresenius Kabi Bad Homburg, Germany	Oncology Immunology	Commercial	VIEW
63.	GSK plc London, United Kingdom	Oncology Infectious Disease Vaccines	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
64.	Gedeon Richter Budapest, Hungary	Neuroscience Cardiovascular	Commercial	VIEW
65.	Getz Pharma Karachi, Pakistan	Gastroenterology Oncology Infectious Disease+1	Commercial	VIEW
66.	Gilead Sciences Foster City, California, United States	Immunology	Commercial	VIEW
67.	Glenmark Pharmaceuticals Mumbai, India	Dermatology Respiratory Oncology+2	Commercial	VIEW
68.	Grand Pharmaceutical Group Wuhan, China	Oncology Ophthalmology Respiratory	Commercial	VIEW
69.	Grupo Farma Caracas, Venezuela	Cardiovascular Gastroenterology Respiratory+1	Commercial	VIEW
70.	Grünenthal Aachen, Germany	Immunology	Commercial	VIEW
71.	Haleon Weybridge, United Kingdom		Commercial	VIEW
72.	Hetero Hyderabad, India	Oncology Cardiovascular Neuroscience+2	Commercial	VIEW
73.	Hetero Healthcare Ltd Hyderabad, India	Oncology Cardiovascular Neuroscience+4	Commercial	VIEW
74.	Hexal AG Holzkirchen, Germany	Oncology Immunology Neuroscience+4	Commercial	VIEW
75.	Hikma Pharmaceuticals London, United Kingdom	Oncology Respiratory Neuroscience+2	Commercial	VIEW
76.	Hudson Insurance Group New York, USA		Commercial	VIEW
77.	Humanwell Healthcare Wuhan, China	Neuroscience Oncology Infectious Disease	Commercial	VIEW
78.	Incepta Pharmaceuticals Ltd. Dhaka, Bangladesh	Oncology Infectious Disease Cardiovascular+3	Commercial	VIEW
79.	Ipca Laboratories Ltd Mumbai, India	Cardiovascular Gastroenterology	Commercial	VIEW
80.	Ipsen Boulogne-Billancourt, France	Oncology Rare Diseases Neuroscience	Commercial	VIEW
81.	Italfarmaco Group Milan, Italy	Rare Diseases Cardiovascular Oncology+2	Commercial	VIEW
82.	JS Group Karachi, Pakistan		N/A	VIEW
83.	JW Pharmaceutical Gwacheon, South Korea	Oncology Immunology Dermatology+2	Commercial	VIEW
84.	Jamp Pharma Group Boucherville, Canada	Cardiovascular Neuroscience Oncology+3	Commercial	VIEW
85.	Johnson & Johnson New Brunswick, New Jersey, USA	Oncology Immunology Infectious Disease+1	Discovery\|Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
86.	Johnson & Johnson New Brunswick, New Jersey, USA	Oncology Immunology Neuroscience+1	Commercial	VIEW
87.	Jubilant Pharmova Limited Noida, India	Oncology Immunology Neuroscience	Phase 2	VIEW
88.	Keenova Therapeutics (formerly Endo Pharmaceuticals/Mallinckrodt Specialty Brands) Dublin, Ireland	Metabolic Gastroenterology Immunology+2	Commercial\|Phase 1-3	VIEW
89.	Kenvue Summit, New Jersey, USA		Commercial	VIEW
90.	Kowa Company, Ltd. Nagoya, Japan	Cardiovascular Ophthalmology Immunology	Commercial	VIEW
91.	Krka Novo mesto, Slovenia	Cardiovascular Gastroenterology Metabolic+1	Commercial	VIEW
92.	LEO Pharma Ballerup, Copenhagen, Denmark	Dermatology	Phase 2, Phase 3, and Commercial	VIEW
93.	Laboratoires Servier Orléans, France	Oncology Immunology Neuroscience+1	Preclinical through Commercial	VIEW
94.	Laboratoires Théa Clermont-Ferrand, France		Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
95.	Laboratoires Théa Clermont-Ferrand, France	Ophthalmology	Commercial	VIEW
96.	Laboratoires Théa Clermont-Ferrand, France		Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
97.	Laboratorios Senosiain Mexico City, Mexico	Gastroenterology Respiratory Oncology+3	Commercial	VIEW
98.	Libbs Farmacêutica São Paulo, Brazil	Oncology Cardiovascular Neuroscience+4	Commercial	VIEW
99.	Lifespan (now Brown University Health) Providence, USA	Oncology Cardiovascular Immunology+1	Commercial	VIEW
100.	Luye Pharma Group Hong Kong, China	Neuroscience Oncology Cardiovascular	Commercial	VIEW
101.	MSD Rahway, New Jersey, USA	Oncology Vaccines Infectious Disease+4	Commercial	VIEW
102.	MSN Laboratories Hyderabad, India	Oncology Cardiovascular Neuroscience+2	Commercial	VIEW
103.	Macleods Pharmaceuticals Limited Mumbai, India	Cardiovascular Metabolic Dermatology+2	Commercial	VIEW
104.	Medac Pharm / medac GmbH Wedel, Germany (near Hamburg)	Oncology Hematology Immunology	Commercial\|Phase 2\|Preclinical	VIEW
105.	Mega Lifesciences Bangkok, Thailand	Oncology Cardiovascular Neuroscience+4	Commercial	VIEW
106.	Menarini Asia-Pacific Singapore, Singapore	Oncology Cardiovascular Dermatology	Commercial	VIEW
107.	Merck & Co., Inc. Rahway, New Jersey, United States	Oncology Immunology Infectious Disease+6	Phase 1-Phase 3 and Commercial	VIEW
108.	Merck KGaA, Darmstadt, Germany Darmstadt, Germany	Oncology Neuroscience Immunology+2	Commercial	VIEW
109.	Nagase & Co., Ltd. Tokyo, Japan	Oncology Neuroscience	Commercial	VIEW
110.	Neutec Pharmaceutical Istanbul, Turkey	Respiratory Oncology Cardiovascular+3	Commercial	VIEW
111.	Novartis Basel, Switzerland	Oncology Immunology Neuroscience+2	Phase 2, Phase 3, Commercial	VIEW
112.	Novo Nordisk Bagsværd, Denmark	Metabolic	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
113.	Novo Nordisk Bagsværd, Denmark	Metabolic Rare Diseases Cardiovascular	Commercial	VIEW
114.	ONO PHARMA UK LTD London, United Kingdom	Oncology Immunology Neuroscience	Phase 1 through Commercial	VIEW
115.	ONO Pharmaceutical Osaka, Japan (Chuo-ku)	Oncology Immunology Neuroscience+1	Phase 1-Phase 3	VIEW
116.	Oracle Corporation Austin, Texas, USA	Oncology Rare Diseases	Commercial	VIEW
117.	Organon Jersey City, USA	Cardiovascular Respiratory Dermatology	Commercial	VIEW
118.	Otsuka Pharmaceutical Chiyoda, Tokyo, Japan	Cardiovascular Rare Diseases	Phase 1 through Commercial	VIEW
119.	Otsuka Pharmaceutical Chiyoda, Tokyo, Japan	Oncology Cardiovascular Immunology+1	Phase 1 through Commercial	VIEW
120.	Otsuka Pharmaceutical Co., Ltd. Tokyo, Japan	Neuroscience Oncology Cardiovascular+2	Commercial	VIEW
121.	PLIVA Zagreb, Croatia	Neuroscience Respiratory Oncology+3	Commercial	VIEW
122.	PPG Industries Pittsburgh, USA		Commercial	VIEW
123.	PT Meprofarm Bandung, Indonesia	Infectious Disease Cardiovascular Gastroenterology+2	Commercial	VIEW
124.	Pfizer New York, United States	Oncology Vaccines Rare Diseases+3	Phase 1-3 and pending approval	VIEW
125.	Pharmascience Inc. Montreal, Canada	Neuroscience Oncology Gastroenterology+2	Commercial	VIEW
126.	Philip Morris International Stamford, Connecticut, USA	Respiratory Cardiovascular	Commercial	VIEW
127.	Pierre Fabre Group Castres, France	Oncology Dermatology Rare Diseases	Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
128.	Radiant Pharmaceuticals Limited Dhaka, Bangladesh	Oncology Neuroscience Gastroenterology+1	Commercial	VIEW
129.	Reckitt Slough, United Kingdom		Commercial	VIEW
130.	Recordati S.p.A. Milan, Italy	Rare Diseases Metabolic Oncology+2	Commercial	VIEW
131.	Renata PLC Dhaka, Bangladesh	Oncology Cardiovascular Neuroscience+1	Commercial	VIEW
132.	Roche Basel, Switzerland	Oncology Immunology Neuroscience+4	Commercial	VIEW
133.	Roche Basel, Switzerland	Oncology Immunology Neuroscience+4	Discovery\|Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
134.	STADA Arzneimittel AG Bad Vilbel, Germany	Oncology Neuroscience Immunology+1	Commercial	VIEW
135.	STADA Arzneimittel AG Bad Vilbel, Germany	Oncology Immunology Neuroscience+1	Commercial	VIEW
136.	Sandoz Basel, Switzerland	Oncology Immunology Neuroscience+3	Commercial	VIEW
137.	Sandoz Group AG Basel, Switzerland	Oncology Immunology Metabolic+3	Commercial	VIEW
138.	Sanofi Paris, France	Immunology Oncology Neuroscience+5	Preclinical through Phase 3	VIEW
139.	Scientific Centre of Drug and Medical Technology Expertise (SCDMTE) Yerevan, Armenia		Commercial	VIEW
140.	Sino Biopharmaceutical Limited Hong Kong (Corporate) / Beijing (Operations), China	Oncology Respiratory	Commercial	VIEW
141.	Sinopharm Beijing, China	Infectious Disease Oncology Immunology+1	Commercial	VIEW
142.	Sopan Pharmaceuticals Limited Lalitpur, Nepal	Respiratory Gastroenterology Infectious Disease+2	Commercial	VIEW
143.	Sopharma AD Sofia, Bulgaria	Cardiovascular Neuroscience Gastroenterology+3	Commercial	VIEW
144.	Sotex Moscow, Russia	Neuroscience Oncology	Commercial	VIEW
145.	Square Pharmaceuticals PLC Dhaka, Bangladesh	Cardiovascular Gastroenterology Neuroscience+4	Commercial	VIEW
146.	St. John Fisher University Rochester, New York, USA		Discovery	VIEW
147.	Sumitomo Pharma America, Inc. Marlborough, USA	Oncology Rare Diseases	Commercial	VIEW
148.	Takeda Pharmaceutical Company Tokyo, Japan	Oncology Rare Diseases Neuroscience+3	Phase 3	VIEW
149.	Tanabe Pharma Corporation Osaka, Japan	Neuroscience Immunology Metabolic+2	Commercial	VIEW
150.	Teva Pharmaceutical Industries Ltd. Tel Aviv, Israel	Neuroscience Immunology Oncology+3	Commercial	VIEW
151.	Teva Pharmaceutical Industries Ltd. Tel Aviv, Israel	Neuroscience Oncology Respiratory+2	Commercial	VIEW
152.	The Coca-Cola Company Atlanta, USA		N/A	VIEW
153.	Torrent Pharmaceuticals Ahmedabad, India	Cardiovascular Neuroscience Oncology+1	Commercial	VIEW
154.	UCB Brussels, Belgium	Immunology Neuroscience Rare Diseases	Commercial	VIEW
155.	UPSA Agen, France	Gastroenterology	Commercial	VIEW
156.	Viatris Canonsburg, Pennsylvania, United States	Cardiovascular Infectious Disease Oncology+4	Phase 1 to Commercial	VIEW
157.	Virbac India Mumbai, India	Dermatology Vaccines	Commercial	VIEW
158.	Wockhardt Mumbai, India	Metabolic Respiratory Neuroscience	Commercial	VIEW
159.	Wörwag Pharma Böblingen, Germany		Commercial	VIEW
160.	Yifan Pharmaceutical Co., Ltd. Hangzhou, China	Oncology	Phase 2-3, Commercial	VIEW
161.	Zuellig Pharma Singapore, Singapore	Oncology Immunology Neuroscience+1	Commercial	VIEW
162.	Zydus Lifesciences Limited Ahmedabad, India	Oncology Ophthalmology Immunology+4	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
163.	phactMI Gainesville, Florida, USA		Commercial	VIEW
164.	ČSOB Finančná skupina Bratislava, Slovakia		N/A	VIEW